[ET Net News Agency, 8 June 2026] HSBC raised the target price for Wuxi Bio (02269) to HKD45.8 from HKD44 and maintained the "buy" rating.
The research house said it raises 2027-28e adjusted NP estimates by 8-18%. (rc)
The research house said it raises 2027-28e adjusted NP estimates by 8-18%. (rc)